BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30354840)

  • 1. Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson's disease.
    Zhao Y; Xi G
    Pharm Biol; 2018 Dec; 56(1):450-454. PubMed ID: 30354840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Puerarin promoted proliferation and differentiation of dopamine-producing cells in Parkinson's animal models.
    Shiying L; Xinhui Q; Guanghua J; Feng N; Feng L; Shumei C; Fan H
    Biomed Pharmacother; 2018 Oct; 106():1236-1242. PubMed ID: 30119192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic Neuronal Differentiation from the Forebrain-Derived Human Neural Stem Cells Induced in Cultures by Using a Combination of BMP-7 and Pramipexole with Growth Factors.
    Yang H; Wang J; Wang F; Liu X; Chen H; Duan W; Qu T
    Front Neural Circuits; 2016; 10():29. PubMed ID: 27147976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zuckerkandl's organ improves long-term survival and function of neural stem cell derived dopaminergic neurons in Parkinsonian rats.
    Chaturvedi RK; Shukla S; Seth K; Agrawal AK
    Exp Neurol; 2008 Apr; 210(2):608-23. PubMed ID: 18272152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
    Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
    Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
    Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brn4 and TH synergistically promote the differentiation of neural stem cells into dopaminergic neurons.
    Tan X; Zhang L; Zhu H; Qin J; Tian M; Dong C; Li H; Jin G
    Neurosci Lett; 2014 Jun; 571():23-8. PubMed ID: 24769320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
    Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
    Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of neural stem cells co-transfected with Nurr1 and Brn4 for treatment of Parkinsonian rats.
    Tan X; Zhang L; Qin J; Tian M; Zhu H; Dong C; Zhao H; Jin G
    Int J Dev Neurosci; 2013 Feb; 31(1):82-7. PubMed ID: 23085081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease.
    Jalewa J; Sharma MK; Gengler S; Hölscher C
    Neuropharmacology; 2017 May; 117():238-248. PubMed ID: 28223210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditioned medium from human amniotic epithelial cells may induce the differentiation of human umbilical cord blood mesenchymal stem cells into dopaminergic neuron-like cells.
    Yang S; Sun HM; Yan JH; Xue H; Wu B; Dong F; Li WS; Ji FQ; Zhou DS
    J Neurosci Res; 2013 Jul; 91(7):978-86. PubMed ID: 23633297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H; Jia L; Chen X; Shi L; Xie J
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral function of bone marrow multipotent adult progenitor cells after transplantation in Parkinson's disease rat models.
    Zhang N; Zhou H; Wang H; Yu L; Li Z; Xu H; Wang M
    Transplant Proc; 2013 Mar; 45(2):719-25. PubMed ID: 23498812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Han F; Wang W; Chen B; Chen C; Li S; Lu X; Duan J; Zhang Y; Zhang YA; Guo W; Li G
    Cytotherapy; 2015 May; 17(5):665-79. PubMed ID: 25747741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
    Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
    Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. bFGF promotes the differentiation and effectiveness of human bone marrow mesenchymal stem cells in a rotenone model for Parkinson's disease.
    Xiong N; Yang H; Liu L; Xiong J; Zhang Z; Zhang X; Jia M; Huang J; Zhang Z; Mohamed AA; Lin Z; Wang T
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):411-422. PubMed ID: 23770451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.
    Berghauzen-Maciejewska K; Wardas J; Kosmowska B; Domin H; Śmiałowska M; Głowacka U; Ossowska K
    Neuroscience; 2016 Feb; 314():22-34. PubMed ID: 26628402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Puerarin protects dopaminergic neurons in Parkinson's disease models.
    Zhang X; Xiong J; Liu S; Wang L; Huang J; Liu L; Yang J; Zhang G; Guo K; Zhang Z; Wu P; Wang D; Lin Z; Xiong N; Wang T
    Neuroscience; 2014 Nov; 280():88-98. PubMed ID: 25218963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.